Lost Profits Not Recoverable For Convoyed Sales Without Adequate Relationship Between Components
Client Alert | 1 min read | 01.30.08
In American Seating Co. v. USSC Group, Inc. (Nos. 2007-1112, 2007-1135; January 29, 2008), the Federal Circuit affirms, inter alia, a motion for judgment as a matter of law setting aside a portion of a jury verdict compensating patentee American Seating for convoyed sales of passenger seats related to USSC's infringement of a patent for an ADA-compliant, wheelchair restraint device for mass transit vehicles.
The Court observes that a "patentee may recover lost profits on unpatented components sold with a patented item, a convoyed sale, if both the patented and unpatented products 'together were considered to be components of a single assembly or parts of a complete machine, or they together constituted a functional unit.'" Reviewing the evidence, the Court notes that the patent does not cover passenger seats, the restraint device operates independently of the passenger seats, and bus buyers do not require passenger seats and restraint devices be purchased from the same company. Thus, without an interrelated or functional relationship between the seats and the restraint device, the Court finds that "the district court was correct that the jury has no basis to conclude that lost profits on collateral sales of passenger seats were due American Seating."
Insights
Client Alert | 11 min read | 12.15.25
New York LLC Transparency Act: Key Requirements and Deadlines
On January 1, 2026 (“Effective Date”), the New York LLC Transparency Act ("New York Act”) is scheduled to take effect, introducing new disclosure requirements for limited liability companies (“LLCs”) formed or registered to do business in New York State. The New York Act is expected to impose the type of broad beneficial ownership requirements the federal CTA and rules implementing it was designed to require, before the federal government’s decision to limit the scope of the CTA’s beneficial ownership reporting requirements to foreign companies and foreign beneficial owners.
Client Alert | 7 min read | 12.15.25
The New EU “Pharma Package:” EU Reaches Landmark Deal on Pharma Package
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
